DCF Advisers, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 62 filers reported holding OVID THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$116,851
-45.0%
30,430
-53.0%
0.06%
-42.9%
Q2 2023$212,426
+20.6%
64,764
-5.1%
0.11%
+3.7%
Q1 2023$176,120
+34.8%
68,264
-2.8%
0.11%
+22.7%
Q4 2022$130,691
-56.3%
70,264
-56.8%
0.09%
-54.4%
Q3 2022$299,000
-2.0%
162,701
+14.8%
0.19%
+6.0%
Q2 2022$305,000
-31.5%
141,7010.0%0.18%
-6.7%
Q1 2022$445,000
-2.2%
141,7010.0%0.20%
+5.4%
Q4 2021$455,000
-4.4%
141,7010.0%0.18%
-11.9%
Q3 2021$476,000
-12.8%
141,701
+1.4%
0.21%
+8.8%
Q2 2021$546,000
+24.7%
139,701
+28.2%
0.19%
+1.6%
Q1 2021$438,000109,0010.19%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,006,185$12,860,0005.90%
GLOBEFLEX CAPITAL L P 2,794,834$8,972,0000.92%
BVF INC/IL 6,631,051$21,286,0000.77%
EcoR1 Capital, LLC 6,082,200$19,524,0000.62%
CHI Advisors LLC 400,000$1,284,0000.43%
Ikarian Capital, LLC 705,082$2,264,0000.34%
Artal Group S.A. 2,500,000$8,025,0000.22%
DCF Advisers, LLC 141,701$455,0000.18%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,462,0000.07%
ACADIAN ASSET MANAGEMENT LLC 2,040,084$6,543,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders